Rui Luo
- Infectious Diseases top 10%
- Molecular Biology
- Neurology
- Epidemiology
- Industrial and Manufacturing Engineering top 10%
- Co-authors
- Hangping YaoKaijin XuLingjuan HeXi YangLin LiuTingbo LiangXingjiang HuXiaoyang Lu
- Topics
- Liver Disease Diagnosis and Treatment (4 papers)COVID-19 Clinical Research Studies (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)
- Partner nations
- ChinaSingaporeNew Zealand
In The Last Decade
Rui Luo
21 papers receiving 393 citations
Peers
Comparison fields: 5 of 104
- Infectious Diseases 211
- Molecular Biology 105
- Neurology 80
- Epidemiology 52
- Industrial and Manufacturing Engineering 41
Countries citing papers authored by Rui Luo
This map shows the geographic impact of Rui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Luo more than expected).
Fields of papers citing papers by Rui Luo
This network shows the impact of papers produced by Rui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Luo. The network helps show where Rui Luo may publish in the future.
Co-authorship network of co-authors of Rui Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Rui Luo. A scholar is included among the top collaborators of Rui Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Luo. Rui Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 15 | |
| 10 | 2 | |
| 11 | 15 | |
| 12 | 22 | |
| 13 | 24 | |
| 14 | 23 | |
| 15 | 65 | |
| 16 | 133 | |
| 17 | 49 | |
| 18 | 1 | |
| 19 | 10 | |
| 20 | 5 |
About Rui Luo
Rui Luo is a scholar working on Biological Psychiatry, Hepatology and Infectious Diseases, having authored 27 papers that have together received 401 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), COVID-19 Clinical Research Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Infectious Diseases (211 citations), Neurology (80 citations) and Industrial and Manufacturing Engineering (41 citations). Rui Luo has collaborated with scholars based in China, Singapore and New Zealand. Frequent co-authors include Hangping Yao, Kaijin Xu, Lingjuan He, Xi Yang, Lin Liu, Tingbo Liang, Xingjiang Hu, Xiaoyang Lu, Yunqing Qiu and Qingwei Zhao. Their work appears in journals such as Advanced Materials, Biomaterials and Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.